Skip to search formSkip to main contentSkip to account menu

NVP ABE171

Known as: 4-(8-benzo(1,2,5)oxadiazol-5-yl-(1,7)naphthyridin-6-yl)benzoic acid, NVP-ABE171, NVPABE171 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

NaphthyridinesOxadiazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma
Abstract Diffuse large B-cell lymphoma (DLBCL) is the most frequent aggressive lymphoma, with a great demand for novel treatments… 
2012
2012
Marked differences in the signaling requirements for expression of CD203c and CD11b versus CD63 expression and histamine release in human basophils.
Many techniques are being used to examine the status of circulating human basophils including the enhanced expression of a… 
2012
2012
Abstract LB-122: A phase I dose escalation study of NVP-BGJ398, a selective pan FGFR inhibitor in genetically preselected advanced solid tumors
The family of fibroblast growth factors (FGFs) and FGF receptors (FGFRs) plays a critical role in cell proliferation and survival… 
Highly Cited
2008
Highly Cited
2008
Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma
We as well as others have recently shown that Hsp90 is overexpressed in multiple myeloma (MM) and critically contributes to… 
2008
2008
Synthesis and characterization of DNA adducts from the HIV reverse transcriptase inhibitor nevirapine.
Nevirapine (NVP) is a non-nucleoside reverse transcriptase inhibitor used against the human immunodeficiency virus type 1 (HIV-1… 
Highly Cited
2006
Highly Cited
2006
Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag.
Highly Cited
2004
Highly Cited
2004
Tumor Cell and Endothelial Cell Therapy of Oral Cancer by Dual Tyrosine Kinase Receptor Blockade
Expression of the epidermal growth factor (EGF) and activation of its receptor (EGFR), a tyrosine kinase, are associated with… 
2004
2004
K579, a slow-binding inhibitor of dipeptidyl peptidase IV, is a long-acting hypoglycemic agent.
Highly Cited
2002
Highly Cited
2002
1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(S)-pyrrolidinecarbonitrile: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties.
Dipeptidyl peptidase IV (DPP-IV) inhibition has the potential to become a valuable therapy for type 2 diabetes. We report the… 
Highly Cited
2002
Highly Cited
2002
Dipeptidyl peptidase IV inhibition improves impaired glucose tolerance in high-fat diet-fed rats: study using a Fischer 344 rat substrain deficient in its enzyme activity.
This study was performed to determine the effects of a high-fat diet on glucose metabolism after an oral glucose challenge in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)